Technology News and Research

RSS

Boehringer Ingelheim awards milestone payment to Xencor

Xencor, Inc. announced today that the Company received a milestone payment from Boehringer Ingelheim. The payment was triggered by the regulatory submission for Phase 1 clinical trials of a novel monoclonal antibody that was optimized using one of Xencor's XmAb Fc (constant fragment) technology platforms under a technology license agreement entered in February 2007.

13 Oct 2010

NHC enter agreement with Attain to offer new program for IVF fertility treatments

IntegraMed America, Inc. the leader in developing, marketing and managing specialty healthcare facilities in the fertility and vein care markets, today announced that its Attain Fertility Centers division has entered into an agreement with The New Hope Center for Reproductive Medicine (NHC) to begin offering the Attain IVF family of specialty financing Programs.

13 Oct 2010

DoD awards $1.5 million grant to study nanoemulsion-based therapies for preventing burn wound infections

Researchers from NanoBio Corporation and the University of Michigan Medical School today announced the receipt of a $1.5 million grant from the Department of Defense (DoD) to study the use of nanoemulsion-based therapies for protection against burn and wound infections.

13 Oct 2010

Retina Implant announces opening of new manufacturing plant in Tübingen-Reutlingen

Retina Implant AG, a leading developer of subretinal implants for the visually impaired, today announced the opening of a new manufacturing plant to meet anticipated demand for their implants. The company's second human clinical trial will be expanding outside of Germany in early 2011 to European countries including the U.K. and Italy and discussions are underway for potential clinical trials in the United States and Asia. Also looking ahead, the new facility meets manufacturing capabilities required for CE mark approval.

13 Oct 2010

Redesigned version of CTC-Chip effective in capturing rare circulating tumor cells

A redesigned version of the CTC-Chip a microchip-based device for capturing rare circulating tumor cells (CTCs) appears to be more effective and should be easier to manufacture than the original. Called the HB-(herringbone) Chip, the new device also may provide more comprehensive and easily accessible data from captured tumor cells.

13 Oct 2010

Tecan, Luminex collaborate to develop automated newborn screening solution

The Tecan Group and Luminex Corporation have announced that they will collaborate on the development of a new automated newborn screening solution that will provide faster results for infants' potential health concerns.

From Tecan 13 Oct 2010

Cardiogenesis initiates enrollment in PHOENIX System Feasibility Study

Cardiogenesis Corporation, a leading developer of surgical products used in the treatment of diffuse coronary artery disease, reported the enrollment of the first two patients in its PHOENIX Feasibility Study. Dr. Guillermo Reyes at La Princesa Hospital, Madrid, Spain performed the procedures utilizing the company's proprietary PHOENIX System that combines the intramyocardial delivery of stem cells with transmyocardial revascularization (TMR).

13 Oct 2010

Centice introduces new PINPOINT Rx system for drug identification

Centice Corporation, a pioneer in chemical verification and identification using Raman spectroscopy and computational sensor technology, announced today the availability of the new PINPOINT Rx™ system. Combining advanced spectroscopy hardware technology, analytical software and internal databases, PINPOINT Rx™ captures the spectral signature of a prescription drug and checks this signature against a known database.

13 Oct 2010

QIAGEN, Abbott enter agreement to strengthen testing menus for automated in-vitro diagnostic applications

QIAGEN and Abbott today announced that they have entered into an agreement that significantly strengthens both companies' testing menus for automated in-vitro diagnostic applications in the United States and Canada. Financial terms were not disclosed.

From QIAGEN Manchester Limited 13 Oct 2010

Incept completes first U.S. human clinical trial of SMART Start Embryo Culture System

Incept BioSystems, Inc. a privately-held biomedical device company using patented, microfluidic technology developed at the University of Michigan, announced today the completion of the first U.S. human clinical trial of its proprietary, SMART Start Embryo Culture System, and the recent submission of a 510(k) application to the U.S. Food & Drug Administration.

13 Oct 2010

Australian women stressed and overweight: Survey

In a poll known as “Australia's Biggest Health Check” 26,000 responders showed that Australia's women feel stressed out and unfit and overworked. It also shows that they have barely half an hour of leisure time per day and the mismatch between how much sex women want versus what they get. The survey was promoted via two magazines - Women's Health and Prevention - and also had the backing of Priceline and the Seven Network’s Sunrise program. There were 24,500 women and 1,500 men in on the poll.

12 Oct 2010

Exiqon introduces on-line microRNA qPCR assay design software

Exiqon A/S, a leading supplier of high-value gene expression analysis products, today announced the extension of the miRCURY LNA microRNA PCR product line with the launch of a novel bioinformatics software for the design of custom qPCR assays for microRNA quantification.

12 Oct 2010

Buck survey finds health care costs projected to increase in 2011

As a number of health care reform provisions go into effect for employer plans in 2011, costs for the most popular types of plans are projected to increase by more than 10 percent.

12 Oct 2010

Elsevier, ASIP to publish The American Journal of Pathology

Elsevier, a world-leading publisher of scientific, technical and medical information products and services, is pleased to announce that as of January 2011 Elsevier will publish The American Journal of Pathology (AJP) in partnership with the American Society for Investigative Pathology (ASIP).

12 Oct 2010

PlastiPure awarded NIH and NSF grants to develop EA-Free material and products

PlastiPure, a safe plastics technology company, announced today that it has received two grants from the National Institute of Environmental Health and Safety (NIEHS), a division of the NIH, and an additional grant from the National Science Foundation (NSF). Collectively the grants fund formulation of a replacement for polycarbonate that is free of estrogenic activity (EA-Free), creating flexible food packaging that contains no EA, and developing a verifiably EA-Free baby bottle.

12 Oct 2010

Rad51 protein plays a key role in DNA protection

Cancer Research UK scientists have shed new light on the vital role that a protein plays in protecting our DNA, reveals a study published in Nature Structural and Molecular Biology today.

12 Oct 2010

OICR announces equity investment in Privacy Analytics

The Ontario Institute for Cancer Research (OICR) today announced it has made an equity investment in Privacy Analytics Inc., an Ontario company that is developing a software platform to help organizations such as health centers disclose detailed disease and treatment data without compromising individual privacy.

12 Oct 2010

Tryton Medical enrolls first patient in registry study

Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that the first patient has been enrolled in E-Tryton Italy, a registry study of the company's Tryton Side Branch Stent System.

12 Oct 2010

ArQule and Daiichi Sankyo expand collaboration to produce drug candidates for cancer

ArQule, Inc. and Daiichi Sankyo Co., Ltd. today announced the expansion of their research, development and license agreement for the discovery of novel kinase inhibitors in the field of oncology. This expanded agreement establishes a third therapeutic target, with an option for a fourth, in the field of oncology, and it includes a two-year extension based on the application of the proprietary ArQule Kinase Inhibitor Platform (AKIP™) technology.

12 Oct 2010

Boyden reports 35% increase in demand for Senior R & D Managers in Life Sciences sector

Fresh hiring decisions are being made at senior management levels, due to CEOs' bold moves to reshape businesses to the more permanent competitive reality, according to the quarterly Boyden Executive Outlook, released today by Boyden Global Executive Search.

12 Oct 2010

Technology News and Research

Boehringer Ingelheim awards milestone payment to Xencor

NHC enter agreement with Attain to offer new program for IVF fertility treatments

DoD awards $1.5 million grant to study nanoemulsion-based therapies for preventing burn wound infections

Retina Implant announces opening of new manufacturing plant in Tübingen-Reutlingen

Redesigned version of CTC-Chip effective in capturing rare circulating tumor cells

Tecan, Luminex collaborate to develop automated newborn screening solution

Cardiogenesis initiates enrollment in PHOENIX System Feasibility Study

Centice introduces new PINPOINT Rx system for drug identification

QIAGEN, Abbott enter agreement to strengthen testing menus for automated in-vitro diagnostic applications

Incept completes first U.S. human clinical trial of SMART Start Embryo Culture System

Australian women stressed and overweight: Survey

Exiqon introduces on-line microRNA qPCR assay design software

Buck survey finds health care costs projected to increase in 2011

Elsevier, ASIP to publish The American Journal of Pathology

PlastiPure awarded NIH and NSF grants to develop EA-Free material and products

Rad51 protein plays a key role in DNA protection

OICR announces equity investment in Privacy Analytics

Tryton Medical enrolls first patient in registry study

ArQule and Daiichi Sankyo expand collaboration to produce drug candidates for cancer

Boyden reports 35% increase in demand for Senior R & D Managers in Life Sciences sector

Industry Focus eBook - Life Science Microscopy (2nd Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News